Call to Include Breastfeeding As a Synergistic Approach to Vaccines for Prevention of Respiratory Syncytial Virus Disease

Overview

Journal Int Breastfeed J

Publisher Biomed Central

Date 2025 Mar 3

PMID 40033309

Authors

Laura Fischer

Elochukwu Okanmelu

Melissa Ann Theurich

Affiliations

Soon will be listed here.

Abstract

Background: Infections with respiratory syncytial virus (RSV) in infancy and early childhood are very common. RSV is the leading cause of bronchiolitis and pneumonia and substantially contributes to the morbidity and mortality of infants and young children worldwide. Until very recently, there have been no vaccines available for prevention and there are no curative treatments for RSV. Two novel pharmaceutical approaches for RSV prevention became available in 2024 namely immunization of mothers during pregnancy and immunoprophylaxis of infants. Since then, a series of scientific papers as well as national and international guidance have been published to encourage parents to vaccinate themselves or their children. Despite strong evidence that breastfeeding is an important non-pharmacological approach for prevention of severe RSV outcomes, recent scientific papers and public health communications have neglected breastfeeding as a core RSV-preventive strategy. This commentary highlights epidemiological evidence of the protective effects of breastfeeding as a key non-pharmacological intervention, discussing its synergistic role in RSV prevention and supportive role in the care of sick infants.

Breastfeeding And Rsv: Breastfeeding has been shown to reduce the rate and severity of RSV-associated outcomes, including hospitalization and mortality. While exclusive breastfeeding is most protective, even one month of breastfeeding was associated with a reduced likelihood of Intensive Care Unit admission and the need of mechanical ventilation in RSV-infected infants. The benefits of breastfeeding for RSV prevention and supportive care have been demonstrated in epidemiological studies in low-, middle- and high-income settings and are especially important for small, premature and sick infants.

Conclusion: Breastfeeding is an overlooked sustainable strategy for the universal prevention of severe outcomes and serves as supportive care of RSV-associated disease in infancy, especially in vulnerable population groups. Breastfeeding should be encouraged alongside vaccines in all public health communication, by health providers during pre- and postnatal immunization visits and during infant check-ups. Further, the role of breastfeeding as supportive care of RSV-infected and critically-ill infants should not be overlooked.

References

Liu T, Xu Y, Gong Y, Zheng J, Chen Z . The global burden of disease attributable to preterm birth and low birth weight in 204 countries and territories from 1990 to 2019: An analysis of the Global Burden of Disease Study. J Glob Health. 2024; 14:04109. PMC: 11239190. DOI: 10.7189/jogh.14.04109. View

Kaler J, Hussain A, Patel K, Hernandez T, Ray S . Respiratory Syncytial Virus: A Comprehensive Review of Transmission, Pathophysiology, and Manifestation. Cureus. 2023; 15(3):e36342. PMC: 10111061. DOI: 10.7759/cureus.36342. View

Vassilopoulou E, Agostoni C, Feketea G, Alberti I, Gianni M, Milani G . The Role of Breastfeeding in Acute Respiratory Infections in Infancy. Pediatr Infect Dis J. 2024; 43(11):1090-1099. DOI: 10.1097/INF.0000000000004454. View

Li Y, Wang X, Blau D, Caballero M, Feikin D, Gill C . Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022; 399(10340):2047-2064. PMC: 7613574. DOI: 10.1016/S0140-6736(22)00478-0. View

Wang X, Li Y, Shi T, Bont L, Chu H, Zar H . Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data. Lancet. 2024; 403(10433):1241-1253. DOI: 10.1016/S0140-6736(24)00138-7. View

Mazur N, Caballero M, Nunes M . Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies. Lancet. 2024; 404(10458):1143-1156. DOI: 10.1016/S0140-6736(24)01716-1. View

Hoover J, Eades S, Lam W . Pediatric Antiviral Stewardship: Defining the Potential Role of Ribavirin in Respiratory Syncytial Virus-Associated Lower Respiratory Illness. J Pediatr Pharmacol Ther. 2018; 23(5):372-378. PMC: 6213624. DOI: 10.5863/1551-6776-23.5.372. View

von Linstow M, Hogh M, Nordbo S, Eugen-Olsen J, Koch A, Hogh B . A community study of clinical traits and risk factors for human metapneumovirus and respiratory syncytial virus infection during the first year of life. Eur J Pediatr. 2008; 167(10):1125-33. PMC: 7086915. DOI: 10.1007/s00431-007-0643-4. View

Halasa N, Bont L . Choice overload for RSV prevention-how to form your opinion. Lancet Respir Med. 2024; 12(10):750-752. DOI: 10.1016/S2213-2600(24)00290-X. View

10.

Mineva G, Purtill H, Dunne C, Philip R . Impact of breastfeeding on the incidence and severity of respiratory syncytial virus (RSV)-associated acute lower respiratory infections in infants: a systematic review highlighting the global relevance of primary prevention. BMJ Glob Health. 2023; 8(2). PMC: 9906265. DOI: 10.1136/bmjgh-2022-009693. View

11.

Collins C, Tinker A . Linkages between immunization and breastfeeding promotion programs. J Hum Lact. 1989; 5(4):174-5. DOI: 10.1177/089033448900500412. View

12.

Pecenka C, Sparrow E, Feikin D, Srikantiah P, Darko D, Karikari-Boateng E . Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children. Lancet. 2024; 404(10458):1157-1170. DOI: 10.1016/S0140-6736(24)01699-4. View

13.

Shi T, Balsells E, Wastnedge E, Singleton R, Rasmussen Z, Zar H . Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis. J Glob Health. 2015; 5(2):020416. PMC: 4676580. DOI: 10.7189/jogh.05.020416. View

14.

Deng S, Cong B, Edgoose M, De Wit F, Nair H, Li Y . Risk factors for respiratory syncytial virus-associated acute lower respiratory infection in children under 5 years: An updated systematic review and meta-analysis. Int J Infect Dis. 2024; 146:107125. DOI: 10.1016/j.ijid.2024.107125. View

15.

Krilov L, Anderson E . Respiratory syncytial virus hospitalizations in US preterm infants after the 2014 change in immunoprophylaxis guidance by the American Academy of Pediatrics. J Perinatol. 2020; 40(8):1135-1144. PMC: 7271636. DOI: 10.1038/s41372-020-0689-y. View

16.

Tejada S, Martinez-Reviejo R, Karakoc H, Pena-Lopez Y, Manuel O, Rello J . Ribavirin for Treatment of Subjects with Respiratory Syncytial Virus-Related Infection: A Systematic Review and Meta-Analysis. Adv Ther. 2022; 39(9):4037-4051. DOI: 10.1007/s12325-022-02256-5. View

17.

Tonon K, Chutipongtanate S, Morrow A, Newburg D . Human Milk Oligosaccharides and Respiratory Syncytial Virus Infection in Infants. Adv Nutr. 2024; 15(6):100218. PMC: 11107461. DOI: 10.1016/j.advnut.2024.100218. View

18.

Cheema R, Partridge E, Kair L, Kuhn-Riordon K, Silva A, Bettinelli M . Protecting Breastfeeding during the COVID-19 Pandemic. Am J Perinatol. 2020; 40(3):260-266. PMC: 7872205. DOI: 10.1055/s-0040-1714277. View

19.

Jimenez-Nogueira E, Bueno-Rebollo C, Garcia-Jerez B, Callejon-Fernandez E, Diaz-Torres M, Gonzalez-Jimenez Y . Impact of breastfeeding on ICU admissions and need for mechanical ventilation in infants younger than 6 months with RSV+ bronchiolitis. An observational study. Pediatr Pulmonol. 2024; 59(10):2442-2448. DOI: 10.1002/ppul.27036. View

20.

Jang M, Kim Y, Hong S, Na J, Hwang J, Shin S . Positive association of breastfeeding on respiratory syncytial virus infection in hospitalized infants: a multicenter retrospective study. Clin Exp Pediatr. 2020; 63(4):135-140. PMC: 7170789. DOI: 10.3345/kjp.2019.00402. View